Optimizing outcomes in immunocompromised hosts: Understanding the role of immunotherapy in invasive fungal diseases
10.3389/fmicb.2015.01322
Saved in:
Main Authors: | Ravikumar, S, Win, M.S, Chai, L.Y.A |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Review |
Published: |
2020
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/174131 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
CELL-BASED CANCER IMMUNOTHERAPY: FROM ANTIBODY-DEPENDENT CELLULAR CYTOTOXICITY TO DENDRITIC CELLS THERAPEUTIC VACCINATION
by: TAN WEE KIAT
Published: (2016) -
Using expanded natural killer cells as therapy for invasive aspergillosis
by: Soe, W.M., et al.
Published: (2021) -
Immunomodulation as therapy for fungal infection: Are we closer?
by: Sam, Q.H., et al.
Published: (2020) -
Research advance of natural products in tumor immunotherapy
by: Huo, Jin-Ling, et al.
Published: (2023) -
CD28 CO-STIMULATION AND CANCER IMMUNOTHERAPY WITH CHIMERIC ANTIGEN RECEPTOR-MODIFIED NATURAL KILLER CELLS
by: YANG CHIYUN
Published: (2018)